Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Tangible Net Worth Ratio

Latest as of June 2026: 96.8%

Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Tangible Net Worth Ratio of 96.8% as of June 2026. This metric is calculated by deducting intangible assets (CN¥447.42 Million) from net assets (CN¥13.82 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 600566 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Tangible NW Ratio

96.8%
Tangible equity / total equity

Net Assets (Equity)

CN¥13.82 Billion
CNY

Intangible Assets

CN¥447.42 Million
Goodwill, patents, brand value

Total Assets

CN¥17.01 Billion
CNY

Hubei Jumpcan Pharmaceutical Co Ltd Tangible Net Worth Ratio (1998–2025)

This chart shows how Hubei Jumpcan Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 28 annual periods from 1998 to 2025. As of June 2026, the ratio stands at 96.8%, reflecting net assets of CN¥13.82 Billion with intangible assets of CN¥447.42 Million CNY. For live market cap and overall valuation, see 600566 market cap overview.

Annual Tangible Net Worth Ratio for Hubei Jumpcan Pharmaceutical Co Ltd (1998–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for Hubei Jumpcan Pharmaceutical Co Ltd from 1998 to 2025, covering 28 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Hubei Jumpcan Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 97.7% CN¥14.63 Billion CN¥337.96 Million CN¥17.70 Billion ▼ -0.2 pp
2024 97.9% CN¥14.73 Billion CN¥310.74 Million CN¥18.46 Billion ▲ +0.3 pp
2023 97.6% CN¥13.37 Billion CN¥315.70 Million CN¥18.14 Billion ▲ +0.5 pp
2022 97.2% CN¥11.35 Billion CN¥320.62 Million CN¥14.98 Billion ▲ +0.2 pp
2021 96.9% CN¥9.13 Billion CN¥280.04 Million CN¥12.13 Billion ▲ +0.6 pp
2020 96.3% CN¥7.76 Billion CN¥283.84 Million CN¥10.52 Billion ▲ +1.8 pp
2019 94.5% CN¥6.10 Billion CN¥335.83 Million CN¥8.66 Billion ▲ +0.4 pp
2018 94.1% CN¥5.46 Billion CN¥321.28 Million CN¥7.80 Billion ▼ -0.8 pp
2017 94.9% CN¥4.40 Billion CN¥222.59 Million CN¥6.66 Billion ▲ +1.1 pp
2016 93.9% CN¥3.69 Billion CN¥225.64 Million CN¥4.99 Billion ▲ +1.6 pp
2015 92.3% CN¥2.71 Billion CN¥209.78 Million CN¥3.59 Billion ▼ -1.6 pp
2014 93.8% CN¥2.29 Billion CN¥141.34 Million CN¥3.36 Billion ▲ +5.2 pp
2013 88.6% CN¥1.15 Billion CN¥131.27 Million CN¥2.01 Billion ▼ -6.3 pp
2012 94.9% CN¥490.80 Million CN¥25.16 Million CN¥992.87 Million ▼ -0.2 pp
2011 95.1% CN¥526.82 Million CN¥25.96 Million CN¥961.82 Million ▲ +0.2 pp
2010 94.9% CN¥520.27 Million CN¥26.76 Million CN¥863.16 Million ▲ +0.2 pp
2009 94.6% CN¥512.85 Million CN¥27.56 Million CN¥836.22 Million ▲ +0.0 pp
2008 94.6% CN¥506.18 Million CN¥27.34 Million CN¥829.61 Million ▲ +0.2 pp
2007 94.4% CN¥498.83 Million CN¥28.05 Million CN¥802.32 Million ▲ +7.8 pp
2006 86.6% CN¥485.82 Million CN¥65.29 Million CN¥786.51 Million ▲ +0.6 pp
2005 86.0% CN¥480.25 Million CN¥67.23 Million CN¥732.21 Million ▲ +0.6 pp
2004 85.4% CN¥473.92 Million CN¥69.17 Million CN¥697.90 Million ▲ +0.3 pp
2003 85.1% CN¥466.47 Million CN¥69.58 Million CN¥650.39 Million ▲ +0.7 pp
2002 84.4% CN¥459.05 Million CN¥71.49 Million CN¥607.22 Million ▼ -8.8 pp
2001 93.2% CN¥449.57 Million CN¥30.45 Million CN¥582.65 Million ▲ +14.5 pp
2000 78.7% CN¥140.01 Million CN¥29.78 Million CN¥223.38 Million ▲ +3.0 pp
1999 75.7% CN¥125.46 Million CN¥30.43 Million CN¥196.69 Million ▲ +4.4 pp
1998 71.3% CN¥108.44 Million CN¥31.08 Million CN¥186.23 Million
pp = percentage points